FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W93049803> ?p ?o ?g. }

• W93049803 endingPage "589" @default.
• W93049803 startingPage "580" @default.
• W93049803 abstract "This study sought to assess whether intracoronary adenosine or nitroprusside following thrombus aspiration (TA) is superior to TA alone for the prevention of microvascular obstruction (MVO) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).MVO, due to its multifactorial pathogenesis, still occurs after TA in a sizeable portion of patients.We performed a placebo-controlled, randomized, open-label, blind-examination, multicenter trial. A total of 240 STEMI patients with Thrombolysis In Myocardial Infarction (TIMI) flow grade 0/1 were randomly allocated 1:1:1 to receive adenosine (n = 80), nitroprusside (n = 80), or saline (n = 80) given distal to the occluded site after TA. The primary endpoint was the incidence of ST-segment resolution (STR) >70% on surface electrocardiogram at 90 min after PCI. Secondary endpoints were angiographic MVO incidence (TIMI flow grade ≤2 or 3 with a myocardial blush grade <2) and major adverse cardiac event (MACE) rate at 30 days as a composite of cardiac death, myocardial infarction, target lesion revascularization, and heart failure requiring hospitalization.STR >70% occurred in in 71% of adenosine-treated patients, in 54% of nitroprusside-treated patients, and in 51% of saline-treated patients (p = 0.009 and p = 0.75, respectively, vs. saline). Angiographic MVO occurred in 18% of adenosine-treated patients, in 24% of nitroprusside-treated patients, and in 30% of saline-treated patients (p = 0.06 and p = 0.37, respectively, vs. saline). MACE occurred in 10%, 14%, and 20% of patients, respectively (p = 0.08 and p = 0.29 vs. saline).In STEMI patients treated by PCI and TA, the additional intracoronary administration of adenosine, but not that of nitroprusside, results in a significant improvement of MVO, as assessed by STR." @default.
• W93049803 created "2016-06-24" @default.
• W93049803 creator A5000351899 @default.
• W93049803 creator A5004582370 @default.
• W93049803 creator A5006158669 @default.
• W93049803 creator A5018324773 @default.
• W93049803 creator A5020417060 @default.
• W93049803 creator A5027600451 @default.
• W93049803 creator A5029130187 @default.
• W93049803 creator A5031505042 @default.
• W93049803 creator A5032028897 @default.
• W93049803 creator A5037081057 @default.
• W93049803 creator A5045727400 @default.
• W93049803 creator A5048078897 @default.
• W93049803 creator A5053460701 @default.
• W93049803 creator A5057991558 @default.
• W93049803 creator A5058512637 @default.
• W93049803 creator A5062655570 @default.
• W93049803 creator A5078703572 @default.
• W93049803 creator A5079881065 @default.
• W93049803 creator A5080268131 @default.
• W93049803 creator A5081993781 @default.
• W93049803 creator A5090353733 @default.
• W93049803 date "2013-06-01" @default.
• W93049803 modified "2023-10-14" @default.
• W93049803 title "Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction" @default.
• W93049803 cites W111458436 @default.
• W93049803 cites W1493556752 @default.
• W93049803 cites W1547749433 @default.
• W93049803 cites W1658072656 @default.
• W93049803 cites W1776221901 @default.
• W93049803 cites W1976319817 @default.
• W93049803 cites W1980100511 @default.
• W93049803 cites W1981250070 @default.
• W93049803 cites W1982914035 @default.
• W93049803 cites W2003483275 @default.
• W93049803 cites W2005863853 @default.
• W93049803 cites W2010514172 @default.
• W93049803 cites W2013800949 @default.
• W93049803 cites W2014366692 @default.
• W93049803 cites W2021926698 @default.
• W93049803 cites W2028252177 @default.
• W93049803 cites W2036024297 @default.
• W93049803 cites W2041627186 @default.
• W93049803 cites W2063919290 @default.
• W93049803 cites W2069446636 @default.
• W93049803 cites W2074912415 @default.
• W93049803 cites W2076446257 @default.
• W93049803 cites W2081124272 @default.
• W93049803 cites W2083585508 @default.
• W93049803 cites W2085413583 @default.
• W93049803 cites W2099891452 @default.
• W93049803 cites W2100947498 @default.
• W93049803 cites W2105611019 @default.
• W93049803 cites W2106359658 @default.
• W93049803 cites W2113349682 @default.
• W93049803 cites W2113350818 @default.
• W93049803 cites W2129228709 @default.
• W93049803 cites W2136009429 @default.
• W93049803 cites W2140723346 @default.
• W93049803 cites W2166950143 @default.
• W93049803 cites W2169185043 @default.
• W93049803 cites W2333133657 @default.
• W93049803 cites W2417447026 @default.
• W93049803 cites W2547623471 @default.
• W93049803 doi "https://doi.org/10.1016/j.jcin.2013.02.009" @default.
• W93049803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23683738" @default.
• W93049803 hasPublicationYear "2013" @default.
• W93049803 type Work @default.
• W93049803 sameAs 93049803 @default.
• W93049803 citedByCount "93" @default.
• W93049803 countsByYear W930498032013 @default.
• W93049803 countsByYear W930498032014 @default.
• W93049803 countsByYear W930498032015 @default.
• W93049803 countsByYear W930498032016 @default.
• W93049803 countsByYear W930498032017 @default.
• W93049803 countsByYear W930498032018 @default.
• W93049803 countsByYear W930498032019 @default.
• W93049803 countsByYear W930498032020 @default.
• W93049803 countsByYear W930498032021 @default.
• W93049803 countsByYear W930498032022 @default.
• W93049803 countsByYear W930498032023 @default.
• W93049803 crossrefType "journal-article" @default.
• W93049803 hasAuthorship W93049803A5000351899 @default.
• W93049803 hasAuthorship W93049803A5004582370 @default.
• W93049803 hasAuthorship W93049803A5006158669 @default.
• W93049803 hasAuthorship W93049803A5018324773 @default.
• W93049803 hasAuthorship W93049803A5020417060 @default.
• W93049803 hasAuthorship W93049803A5027600451 @default.
• W93049803 hasAuthorship W93049803A5029130187 @default.
• W93049803 hasAuthorship W93049803A5031505042 @default.
• W93049803 hasAuthorship W93049803A5032028897 @default.
• W93049803 hasAuthorship W93049803A5037081057 @default.
• W93049803 hasAuthorship W93049803A5045727400 @default.
• W93049803 hasAuthorship W93049803A5048078897 @default.
• W93049803 hasAuthorship W93049803A5053460701 @default.
• W93049803 hasAuthorship W93049803A5057991558 @default.
• W93049803 hasAuthorship W93049803A5058512637 @default.

• next